Reduced Transfusion During OLT by POC Coagulation Management and TEG Functional Fibrinogen
Open Access
- 1 January 2016
- journal article
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 2 (1) , e49
Abstract
Patients undergoing orthotopic liver transplantation are at high risk of bleeding complications. Several Authors have shown that thromboelastography (TEG)-based coagulation management and the administration of fibrinogen concentrate reduce the need for blood transfusion. We conducted a single-center, retrospective cohort observational study (Modena Polyclinic, Italy) on 386 consecutive patients undergoing liver transplantation. We assessed the impact on resource consumption and patient survival after the introduction of a new TEG-based transfusion algorithm, requiring also the introduction of the fibrinogen functional thromboelastography test and a maximum amplitude of functional fibrinogen thromboelastography transfusion cutoff (7 mm) to direct in administering fibrinogen (2012-2014, n = 118) compared with a purely TEG-based algorithm previously used (2005-2011, n = 268). After 2012, there was a significant decrease in the use of homologous blood (1502 ± 1376 vs 794 ± 717 mL, P < 0.001), fresh frozen plasma (537 ± 798 vs 98 ± 375 mL, P < 0.001), and platelets (158 ± 280 vs 75 ± 148 mL, P < 0.005), whereas the use of fibrinogen increased (0.1 ± 0.5 vs 1.4 ± 1.8 g, P < 0.001). There were no significant differences in 30-day and 6-month survival between the 2 groups. The implementation of a new coagulation management method featuring the addition of the fibrinogen functional thromboelastography test to the TEG test according to an algorithm which provides for the administration of fibrinogen has helped in reducing the need for transfusion in patients undergoing liver transplantation with no impact on their survival.Keywords
This publication has 34 references indexed in Scilit:
- Preoperative predictors of blood component transfusion in living donor liver transplantationAsian Journal of Transfusion Science, 2013
- First-line Therapy with Coagulation Factor Concentrates Combined with Point-of-Care Coagulation Testing Is Associated with Decreased Allogeneic Blood Transfusion in Cardiovascular SurgeryAnesthesiology, 2011
- Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapyCritical Care, 2011
- Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot studyBritish Journal of Anaesthesia, 2009
- Measurement of functional fibrinogen levels using the ThrombelastographJournal of Clinical Anesthesia, 2008
- The Impact of Intraoperative Transfusion of Platelets and Red Blood Cells on Survival After Liver TransplantationAnesthesia & Analgesia, 2008
- Derivation of A Risk Index for the Prediction of Massive Blood Transfusion in Liver TransplantationLiver Transplantation, 2006
- Citrated Blood Does Not Reliably Reflect Fresh Whole Blood Coagulability in Trials of In Vitro HemodilutionAnesthesia & Analgesia, 2003
- Thromboelastography-Guided Transfusion Algorithm Reduces Transfusions in Complex Cardiac SurgeryAnesthesia & Analgesia, 1999
- Thromboelastography-Guided Transfusion Algorithm Reduces Transfusions in Complex Cardiac SurgeryAnesthesia & Analgesia, 1999